Investors

Astellas Venture Management LLC

Astellas Venture Management LLC is the corporate venture capital arm of Astellas Pharma Inc., a global pharmaceutical company headquartered in Japan. Astellas Venture Management invests in emerging biotechnology companies dedicated to the development of new therapeutics and new drug discovery platform technologies. Astellas Venture Management is currently managing four funds totaling approximately $100 million and is based in Menlo Park, California, USA. Learn More

Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, USA, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With four funds, the firm has more than $200 million under management. Learn More

Headlands Ventures, LP

Headland Ventures is an investment partnership focused on early-stage company investing. It is based in Sausalito, California, USA. Learn More

Intersouth Partners

Intersouth Partners is one of the most active and experienced venture funds in the Southeast, having invested in more than 100 private companies over the last two decades. Founded in 1985, Intersouth manages $780 million in seven venture capital limited partnerships, making it the largest venture capital fund in North Carolina and one of the largest in the Southeast. Based in Durham, North Carolina, USA, Intersouth Partners seeks a broad range of investment opportunities in the technology and life sciences sectors. Learn More

Lilly Ventures

Lilly Ventures is a venture capital subsidiary of Eli Lilly and Company and manages $200 million in committed capital, investing in start-up biopharmaceutical and medical technology companies in early through expansion stage investments. The primary goal of Lilly Ventures is to facilitate the success of companies with innovative technologies by providing both financial and intellectual resources to accelerate the management teams' path to success. Lilly Ventures is located in Indianapolis, Indiana, USA. Learn More

Lurie Investment Fund LLC

Lurie Investment Fund, LLC is the venture capital arm of the Ann and Robert H. Lurie Foundation specializing in venture capital and private equity investments. The firm seeks to invest in biomedical community, mainly in medical devices, therapeutics, diagnostics and services, nanotechnology, and MEMS technology. Lurie Investment Fund, LLC is based in Chicago, Illinois, USA.

Novartis Option Fund

The Novartis Option Fund is a $200 million fund that is part of the Novartis Venture Funds. Established in 1996, the Novartis Venture Funds currently manage over $700 million in committed capital and is invested in more than 65 private companies. The objective of the Novartis Option Fund is to seed innovative companies through initial and follow on investments. The initial investment is coupled with an option to a specific therapeutic program providing early validation for the company's technology by a larger pharmaceutical partner. The Novartis Option Fund is located in Basel, Switzerland and Cambridge, Massachusetts, USA. Learn More